Definium Therapeutics Grants Stock Options to New Employees
I'm PortAI, I can summarize articles.
Definium Therapeutics Inc. has granted stock options to two new non-executive employees, totaling 28,640 common shares. The options, effective February 2, 2026, will vest over four years, with 25% vesting on the first anniversary and the remaining 75% in monthly increments. The exercise price is based on the closing price of the shares on the grant date. This announcement was published via Business Wire and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments